chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm sore; Headache; Joint aches; Fatigue; Muscle aches; This non-serious case was reported by a consumer and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: Arm sore), headache (Verbatim: Headache), joint pain (Verbatim: Joint aches), fatigue (Verbatim: Fatigue) and muscle pain (Verbatim: Muscle aches). The outcome of the pain in arm, headache, joint pain, fatigue and muscle pain were not reported.   It was unknown if the reporter considered the pain in arm, headache, joint pain, fatigue and muscle pain to be related to Shingrix.     It was unknown if the company considered the pain in arm, headache, joint pain, fatigue and muscle pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 17-MAR-2023 The patient received dose of Shingrix The patient experienced arm sore, headache, joint aches, muscle aches and fatigue after the vaccination. The reporter consented to follow up.
Still experiencing extreme nausea; Exhaustion weeks after; Headache; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 10Mar2021 at 15:00(at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included kidney pain and cancer. The patient did not have any allergies to medications, food, or other products. Concomitant medications included atorvastatin calcium (LIPITOR) and magnesium (MANUFACTURER UNKNOWN) started on unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the arm left on 16Feb2021 at 18:00 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Mar2021 the patient experienced  extreme nausea, exhaustion weeks after and headache. The patient was not a person who got nausea at all and was active normally. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event extreme nausea, exhaustion weeks after, headache was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
On Friday 10/21/22, I started feeling bad, I had a sore throat. I tested with a home COVID-19 test as my son called to let us know that he had tested positive. I forgot to call my doctor as all this happened over this weekend I will call them once we get later. The weekend was pretty bad with the headache, fever, sore throat and now mucus and coughing. I am now taking MUCINEX to help keep the mucus from settling in my lungs and giving me pneumonia. I am drinking lots of fluid and taking some prednisone that I have on hand.
Pressure and pain in head (possible migraines?), dizziness, extreme sensitivity to caffeine and sometimes food, shortness of breath
1-2 days p/vax had minor redness & soreness-1mo later, wife calls to report ongoing soreness & ?numbness when seen in office only complaint was soreness @ inj site-no redness, irritation, etc noted
C/o burning and pain during and after injection. Had bruise after injection. Pain resolved after 1 week.
Pt received vaccine from outside source. Seen first time for other issues and reported rash and throat congestion after receiving vaccine. Symptoms 1. rash, 2. throat congestion.
fever/ low grade fever; body aches; low grade fever plus a raging headache; This is a spontaneous report received from a contactable consumer. A 60-year-old female patient (Pregnant at the time of vaccination: No) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 30Mar2021 at single dose for COVID-19 immunization. The relevant medical history included diabetes and hypothyroid disease from unspecified date. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on an unspecified date for Covid-19 Immunization. The patient experienced fever, body aches, low grade fever plus a raging headache on 30Mar2021. It was unknown if the patient received treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was resolved on 02Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Injection site swelling (large lump developed under injection site),itching, feeling of heat, and extreme pain with any movement of arm. Also patient states she has pain today along right side of body with pain in hip and down leg. No reported fever. Patient applied ice to injection site and hydrocortisone 1% cream for itching. Patient reported today (one day after injection) that symptoms seem to be resolving.
Patient started having pain/stiffness of neck 2 days after vaccination which continued for about one week and then resolved
Skin irritation; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (Skin irritation) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN IRRITATION (Skin irritation). At the time of the report, SKIN IRRITATION (Skin irritation) outcome was unknown.            Concomitant product was not provided by the reporter.  Treatment information was not provided.
The patient reported a headache, lethargy and nausea with flu-like symptoms. Lasted approximately 36 hours.
Global outbreak of hives, intense itch, and dermatographia. Day 1: Started on my scalp, dorsal neck, and ears; then Days 2 - 10 radiated to all parts of my body. Now (Day 17) they appear spontaneously anywhere on my body throughout the day. If scratched, will become an uncomfortable patch of wheals. If left alone, will go away in an hour or so. Dermatographia persistent 100%.   Treatment: Tapered prednisolone course (40 mg  per day slowly tapered down); Cetirizine 10 mg BID; Famotidine 10 mg BID; Vitamin C supplement. Topical Triamcinolone cream PRN.  25 mg Benadryl added in PM only as needed.   Current Day 17:  Vastly improved but not resolved. When medications wear off ~ q 12 hours, or if I miss a dose, prevalence and intensity of hives starts to ramp up.
pt recv vax 1APR96 & 3APR96 started w/persistent crying >3hr during noc, treated for ear infect;despite resolved ear infect -crying for more than 3hr resumed 10APR96-12APR96
Productive cough; Wheezing; This is a spontaneous report from a contactable physician, the patient. A 71-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the left arm on 20Mar2021 at 13:00 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension, hyperlipidaemia, adult-onset asthma, aortic valve replacement, cataracts and penicillin allergy. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the left arm on 27Feb2021 at 15:00 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 23:00, ten hours after second shot, the patient developed asthma symptoms including a very productive cough and wheezing, which lasted for four days. On second day, the patient was treated for the events with prednisone 40mg/d. Although, the patient had adult-onset asthma but had not received any episode like this in ten years. The symptoms were 90% improved (as reported). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of very productive cough and wheezing was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Vaccine given at 1:30 PM on Friday 2/21/14. Baby was crying inconsolably from 7 PM Friday nite to 9:30 Saturday morning when she fell asleep. No localized reaction noticed and no increased temperature.
Pt received IZ's on 11/16/00 and on 11/17/00, she started vomiting, was very fussy and not sleeping at night. On 11/30/00, she started running a fever of 100F to 101F. I gave her Tylenol to break the fever and I could not get her fever to break. On 12/1/00, around 10:30 AM, she let out a very high pitched scream and started staring into space and was very stiff and acted like she was trying to swallow her tongue. We called 911 and she was taken to the hospital. At the hospital her dx was febrile seizure. On 12/15/00, she started running another fever. which we gave her children's Tylenol and children's Motrin as directed by her physician, we could not get the fever to break and on 12/16/00 at 21:00 PM she started having another seizure and we called 911. She was taken to another hospital by EMS and all their tests came back as normal. From this hospital she was taken to the 1st hospital again by EMS. On 12/16/00, her dx was croup with febrile seizure. On 12/22/00, she was taken to a hospital for an EEG which was also normal. She has an appointment in the neurology clinic at the hospital on 4/10/01.
Information has been received from 2 healthcare worker referring to a patient of unknown age and gender. The patient's medical history ws not reported. On 18-FEB-2015, the patient was received improperly stored (Oka/Merck) VARIVAX (lot # K007979, exp date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
Rash on her leg for 2-3 days, no known contact w/poison oak, only on her leg. No fever. It hurts only a little. Shingles, vesicular scabbing in distribution left ant. Thigh.  1-19-06 Vaccines were given back in 1999 by a different doctor and we do not have any details about MMR and Varicella.
Pt. states experienced itching and hives all over body after receiving live-virus influenza vaccine. Pt. denies taking any medications for symptoms.
Patient received the Moderna vaccine and went to sit in the observation area. Patient began to feel dizziness and nausea shortly afterwards, assisted to stretcher to lie down by RN. Provided with ice packs, juice and a snack. Symptoms resolved after about 20 minutes and patient then stated that he felt much better and felt ready to leave clinic. Ambulating well at time of departure from clinic.
Client reported to EMT observer approx. 15 after receiving vaccine that he felt chills.  Client was led to zero-gravity chair and stated he felt "light headed." After 5 mins. in chair, client reported light headedness decreased. Denied any prior reaction to vaccines. Was advised to remain for 30 mins. V/S @ 1130: BP 96/58, O2 96, RR 66, AOx3.  V/S @ 1138: BP 112/72, HR 65, O2 98, RR 16. V/S @ 1148: BP 114/68, HR 60, O2 99, RR 16. At 11:50am client reported symptoms completely resolved. Client walked away unassisted and with a steady gait. He departed site in his partner's vehicle who drove him home.
Pt recvd flu vax 7OCT91 & began falling & devel leg numbness 15OCT91 & was admitted to the hosp dx w/GBS; MD felt rxn was unrelated to flu vax;
Completed Rabies vaccine series 3 months prior to onset of symptoms. Onset of tingling to arms and hands 4-25-07 - progressed to difficulty walking and facial paralysis within 2-3 days. Diagnosed with [[name]] Barre Syndrome.  09/17/2007 MR received from PCP which included hospital H&P, consult, and D/C Summary as well as F/U OVs for Dx of [[name]] Barre syndrome (DOS 4/30-5/07/2007). Pt initially presented to PCP on 4/25/2007 with c/o numbness and tingling of upper and lower extremities and fingertips x 1 day. Given Naprosyn. Pt then presented to ER on 4/30/2007 with same c/o and progressive weakness in addition.  Pt also c/o mild SOB and mild diarrhea.  Pt fell while attempting to ambulate resulting in ecchymosis of the L knee. Neuro consult PE (+) for weakness.  DTRs 1/4 upper extremeties and absent on lower extremities. Strength 4/5 except 5/5 bilaterally proximal upper extremities. Some decrease in FVC noted during hospitalization. Treated with IVIG with some improvement in weakness and stabilization of respiratory status. BP labile.  Dxwith hypothyroidism during hospitalization. Tranfered to skilled nursing facility for PT. F/U 6/18/07 for GBS -mostly back to normal with some mild weakness in the legs and more winded with exhertion than in past. Dx: [[name]] Barre-almost completely recovered. F/U 7/24/07 completely recovered.
Severe fatigue, groggy/inability to focus, muscle soreness all over body, armpit soreness with lump
Patient seen in the emergency department for shortness of breath beginning that morning. Patient had COVID-19 PCR test and was found to be positive. Patient did not meet criteria for admission and received monoclonal antibodies prior to discharge. Patient died on 10/16/21 which is the same day she was discharged home.
Aprox 2hrs post injection on Saturday afternoon: mild dysphasia and SOB. This evolved over the next 4hrs into full dysphasia and inability to go beyond shallow breathing, lasting aprox 10hrs. Took Benadryl, which helped to relieve the symptoms. Sunday afternoon: Mild SOB, tachycardia, elevated body temps with movement. Any activity ? walking, standing up hand washing dishes,  loading/unloading washer/dryer, sitting and folding laundry -  would induce immediate elevated body temps and tachycardia. Only relief was with ice packs placed on back of neck and under armpits to bring down body temp and heart rate. This lasted 24hrs, from Sunday afternoon ? Monday afternoon. Monday evening: Intense LT hemispheric head/face pain. Placing eyeglasses and mask on face felt like razorblades cutting into my skin. Opening mouth, masticating, would cause extreme pain in LT side of jaw. Moving hair and coming in contact with moving air such as a fan or A/C was excruciating pain to LT hemisphere of head/face. This lasted 12hrs until I was able to take Advil and go sleep. Aprox 0400 Tuesday morning: Pain to the injection site, any movement to arm was very painful, very LROM due to pain for the next 24hrs. Tuesday afternoon: Nausea, dizziness, weakness, and lethargy ? difficulty getting up from seated position and heaviness to extremities restricting movement. Wednesday: Appears major negative reactions have subsided with the exception of LT arm injection site still very tender to touch. No ecchymosis noted; however, large tattoo at location may be masking any noticeable signs.
became forgetful; can't walk; extreme dizziness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 38 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 12May2021 14:45 (Lot number: EW0173, Expiration Date: 31Jul2021) at the age of 38 years as dose 2, single and administered in arm right, administration date 2021 (Lot number: ER8729, Expiration Date: 31Jul2021) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (ongoing), notes: Verbatim: Epilepsy. Concomitant medication(s) included: LAMOTRIGINE taken for epilepsy (ongoing). The following information was reported: DIZZINESS (non-serious) with onset 13May2021, outcome "not recovered", described as "extreme dizziness"; MEMORY IMPAIRMENT (non-serious) with onset 17May2021, outcome "not recovered", described as "became forgetful"; GAIT DISTURBANCE (non-serious) with onset 17May2021, outcome "not recovered", described as "can't walk".  Additional information-Caller reports that after her second dose of the Covid vaccine she had felt extreme dizziness and it's to the point she can't walk and keeps forgetting things.  She wants to know if this was all normal. States the dizziness or bad equilibrium had not been everyday. States she got the second dose on 12May2021 and the day after was when the dizziness started, the 13th. It was not that bad at first the first 2 days and it would not happen everyday, but every few days. It would be some kind of dizziness. Started having a hard time with walking today and since this morning it has become worse and forgetting things has been really bad today and getting worse. States she didn't get any other shots the same day and no problems with vaccines in past. She doesn't get vaccines, not since she was younger. Provides first dose of Covid vaccine was given exactly 2 weeks before the second one at the same time. She did start a new medicine for epilepsy and they are building up on the dose.  Vaccination Facility Type was School/Student Health Clinic. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as None. Additional Vaccines Administered on Same Date of the Pfizer Suspect If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect was None  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician's assistant concerning a 7 year old patient with no pertinent medical history, drug reactions or allergies who on 16-MAR-2001 was vaccinated subcutaneously with a first dose of varicella virus vaccine live (Oka/Merck) (Lot # 635459/0759K). There was no concomitant medication. On 12-SEP-2007 the patient experienced varicella like rash covering entire body. Subsequently, the patient recovered. Medical attention was sought. There was no product quality complaint. There were no lab diagnostic studies performed. Additional information has been requested.
received Boostrix vaccine two years ago and developed hives.; This case was reported by a consumer via call center representative and described the occurrence of hives in a adult female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, less than 2 years after receiving Boostrix, the patient experienced hives. On an unknown date, the outcome of the hives was unknown.   It was unknown if the reporter considered the hives to be related to Boostrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Boostrix vaccine two years ago and developed hives. The reporter did not consent to follow up.
Patient received her Covid vaccine, had no issues and after 30-35 mins, went to the bathroom, felt dizzy and fell, patient was taken by Center, vitals were 150/90, O2 96 %,.  Ambulance  took transported patient because patient stated she had a history of Heart attacks and they felt similar.
two patients received MENQUADFI after the temperature excursion occurred; Initial information received on 08-Feb-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 10 years old male patient who experienced two patients received menquadfi after the temperature excursion occurred while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, TETANUS VACCINE TOXOID (ADACEL).  On 02-Feb-2022, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE  with the dose of 0.5ml with lot U6824AA via intramuscular route in unknown administration site.  On 02-FEB-2022 the patient received menquadfi after the temperature excursion occurred (product temperature excursion issue) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (two patients received MENQUADFI after the temperature excursion occurred).  At time of reporting, the outcome was Unknown for the event two patients received menquadfi after the temperature excursion occurred.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Severe, Additional Details: Patient applied a DEsonide steroid cream, no relief as of yet.
I had severe arm pain that radiates through my entire upper arm. I experienced fatigue, slight fever, chills, and malaise.
This spontaneous case reported by a consumer, describes the occurrence of inflammation (head felt inflamed in different places), headache (painful, bad headache) and myalgia (body aches) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included neurological disorder (NOS) and blood clot. Patient had neurological and blood clot concerns. In 2021, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. In 2021, patient experienced inflammation (head felt inflamed in different places), headache (painful, bad headache) and myalgia (body aches). At the time of the report, inflammation (head felt inflamed in different places), headache (painful, bad headache) and myalgia (body aches) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications or treatment information reported.
Headache, Arthralgia, pain and swelling at site, nech ache Narrative:
2 female adult patients received Shingrix first dose after being exposed to freezing temperatures; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a female patient who received Herpes zoster (Shingrix) (batch number 5954H, expiry date 15-AUG-2025) for prophylaxis.   On 28-AUG-2023, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: 2 female adult patients received Shingrix first dose after being exposed to freezing temperatures).The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK Receipt Date: 29-AUG-2023 The reporter was a medical assistant. The reporter reported that patient received Shingrix dose after being exposed to freezing temperatures, which led to incorrect storage of drug. The reporter consented to follow up. This was 1 of 2 cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2023118050:Same reporter, different patient